Latest Articles
Emily Sue’s life-changing surgery shock that led her to MasterChef Australia - Now To Love
Emily Sue’s life-changing surgery shock that led her to MasterChef Australia Now To Love
Published: May 31, 2026, 8 p.m.
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma - Cureus
Analysis of Tumor-Associated Macrophages (TAM) Using Cluster of Differentiation 68 (CD68) Immunohistochemical Marker in Endometrial Carcinoma Cureus
Published: May 31, 2026, 4:44 p.m.
A gem of a psychological thriller: 7 superb TV shows to watch this week on ITV, Netflix, the BBC and more - MSN
A gem of a psychological thriller: 7 superb TV shows to watch this week on ITV, Netflix, the BBC and more MSN
Published: May 31, 2026, 7:58 a.m.
18-year-old's openness about endometriosis leads to regional first, growing momentum - PembinaValleyOnline
18-year-old's openness about endometriosis leads to regional first, growing momentum PembinaValleyOnline
Published: May 30, 2026, 10:04 a.m.
Amazon Prime members can now save 10 cents a gallon at select gas stations - Mashable
Amazon Prime members can now save 10 cents a gallon at select gas stations Mashable
Published: May 30, 2026, 9 a.m.
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients - Cancer Therapy Advisor
Dostarlimab Plus Chemo May Offer Cure to Some Advanced Endometrial Cancer Patients Cancer Therapy Advisor
Published: May 30, 2026, 4 a.m.
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients - News-Medical
Pembrolizumab combination therapy improves survival in recurrent endometrial cancer patients News-Medical
Published: May 30, 2026, 2:16 a.m.
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC - CancerNetwork
Pembrolizumab Plus Chemotherapy Shows Sustained Survival in Advanced EC CancerNetwork
Published: May 30, 2026, 12:40 a.m.
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer - OncLive
Pembrolizumab Plus Chemotherapy Shows Long-Term OS Benefit in Advanced/Recurrent Endometrial Cancer OncLive
Published: May 29, 2026, 11:57 p.m.
Immunotherapy Addition Demonstrates Sustained Survival Benefits in - Bioengineer.org
Immunotherapy Addition Demonstrates Sustained Survival Benefits in Bioengineer.org
Published: May 29, 2026, 11:56 p.m.
Link copied to clipboard!